Sanofi taps into Insilico Medicine’s AI platform in deal worth up to $1.2bn

(November 10, 2022) | By Rachel Arthur.

Sanofi and Insilico Medicine have announced a multi-year, multi-target strategic research collaboration: leveraging Insilico’s ‘Pharma.AI’ platform to advance drug development for up to six new targets.